Abstracts of the 8th Meeting of the Italian Peripheral Nerve Study Group: 21
Roberto Bianchi(AOL (United States)), Anthony Cerami(Araim Pharmaceuticals (United States)), Costanza Savino(University of Messina), M. Borgna(University of Milan), Giuseppe Lauria(University of Milan), Pietro Ghezzi(Brighton and Sussex Medical School), Guido Cavaletti(Bellvitge University Hospital), N Oggioni(University of Milano-Bicocca), Michael Brines(Northwell Health)
Cited by 0
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k